All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Evaluating Practices in the Treatment of HABP/VABP

Three dates available!
Wednesday, September 4, 2019, 11:00 AM - 12:00 PM CT  -  Register to attend September 4

Thursday, September 19, 2019, 11:00 AM - 12:00 PM CT  -  Register to attend September 19

Wednesday, October 30, 2019, 10:30 AM - 11:30 AM CT  -  Register to attend October 30


A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 View more SIDPEC Activities

Activity Description

Infectious diseases practice is undergoing significant change in the management of nosocomial bacterial pneumonia. Categorized as HABP (hospital-acquired bacterial pneumonia) or VABP (ventilator-associated bacterial pneumonia), rapidly evolving drug resistance has had profound implications on disease progression and mortality. Rising threats from multi-drug resistant organisms, such as Pseudomonas aeruginosa, has created a need for thoughtful stewardship and use of combination antibiotics most likely to provoke a meaningful response. This activity will discuss the prevention and treatment of HABP/VABP for clinical and infectious diseases pharmacists. Special attention will be given to available and emerging treatment options, along with pertinent patient considerations and monitoring strategies.

Learning Objectives

The target audience for this activity includes pharmacists, nurses and physicians. At the completion of this activity, the participant will be able to:

  • Describe key guideline-based recommendations for adults with hospital-acquired and ventilator-associated pneumonia.
  • Discuss the latest antimicrobial treatment strategies for managing patients with pneumonia caused by multi-drug resistant organisms.
  • Explain strategies and resources for managing patients with unique clinical scenarios (such as renal impairment) using new and old antibiotics.
  • Identify strategies to incorporate underutilized antimicrobial stewardship concepts into routine clinical practice.


Rachel Bystritsky, MD
Assistant Professor, Medicine
University of California, School of Medicine
San Francisco, CA

Katherine Gruenberg, PharmD, BCPS
Assistant Professor of Clinical Pharmacy
University of California, San Francisco School of Pharmacy
San Francisco, CA

CE Accreditation


This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-435-L01-P has been assigned to this live knowledge-based activity (initial release date 9-4-2019). This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.


This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.0 contact hour of nurse CE credit.

Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Complete Conference Management (CCM) and ProCE, Inc.

Complete Conference Management (CCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Complete Conference Management (CCM) designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Faculty conflict of interest will be announced prior to the start of the activity.


This activity is supported by an educational grant from Merck.


Webinar Equipment Requirements
-Computer with broadband Internet access
-Soundcard and speakers or headphones for your computer (or dial-in via telephone for audio)
Click here for detailed software requirements.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.